Comments
Loading...
EyePoint Pharmaceuticals (EYPT) Forecast
NewsEarningsEyePoint Pharmaceuticals (EYPT) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEyePoint Pharmaceuticals (NASDAQ:EYPT) Stock Quotes, Forecast and News Summary
EyePoint Pharmaceuticals Stock (NASDAQ: EYPT) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy EyePoint Pharmaceuticals (EYPT) stock?
You can purchase shares of EyePoint Pharmaceuticals (NASDAQ:EYPT) through any online brokerage.
Who are EyePoint Pharmaceuticals (EYPT) competitors?
Other companies in EyePoint Pharmaceuticals’s space includes: Theravance Biopharma (NASDAQ:TBPH), Third Harmonic Bio (NASDAQ:THRD), Zevra Therapeutics (NASDAQ:ZVRA), GH Research (NASDAQ:GHRS) and SNDL (NASDAQ:SNDL).
What is the forecast, or price target, for EyePoint Pharmaceuticals (EYPT) stock?
EyePoint Pharmaceuticals has a consensus price target of $30.50.
What is the current price for EyePoint Pharmaceuticals (EYPT)?
The stock price for EyePoint Pharmaceuticals (NASDAQ: EYPT) is $7.22 last updated December 24, 2024 at 4:03 PM EST.
Does EyePoint Pharmaceuticals (EYPT) pay a dividend?
There are no upcoming dividends for EyePoint Pharmaceuticals.
When is EyePoint Pharmaceuticals (NASDAQ:EYPT) reporting earnings?
EyePoint Pharmaceuticals’s Q4 earnings are confirmed for Thursday, March 6, 2025.
Is EyePoint Pharmaceuticals (EYPT) going to split?
There is no upcoming split for EyePoint Pharmaceuticals.
What sector and industry does EyePoint Pharmaceuticals (EYPT) operate in?
EyePoint Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.